UPDATE: Boston Scientific (BSX) Beats Q1 EPS by 2c; Boosts FY14 Profit Outlook - Correct

Boston Scientific Corp. (NYSE: BSX) reported Q1 EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $1.77 billion versus the consensus estimate of $1.8 billion.

Boston Scientific Corp. sees FY2014 EPS of $0.77-$0.82, versus prior guidance of $0.75-$0.8 and the consensus of $0.78.

Boston Scientific Corp. sees Q2 2014 EPS of $0.18-$0.20, versus the consensus of $0.2. Boston Scientific Corp. sees Q2 2014 revenue of $1.84-1.89 billion, versus the consensus of $1.87 billion.

For earnings history and earnings-related data on Boston Scientific Corp. (BSX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• MP Materials seen largely insulated after China export-control move